References - Therapeutic Strategies in Cancer Biology and Pathology - page 253

Tsai, W.C., Hsu, P.W.C., Lai, T.C., Chau, G.Y., Lin, C.W., Chen, C.M., et al., 2009.
MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of
hepatocellular carcinoma. Hepatology 49, 1571-1582.
Tsoporis, J.N., Izhar, S., Proteau, G., Slaughter, G., Parker, T.G., 2012. S100B-RAGE depend-
ent VEGF secretion by cardiac myocytes induces myofibroblast proliferation. J. Mol.
Cell Cardiol. 52, 464-473.
Tsui, K.H., Chung, L.C., Feng, T.H., Chang, P.L., Juang, H.H., 2012. Upregulation of pros-
tate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion
in prostate carcinoma cells. Int. J. Cancer 130, 2812-2823.
Tsukamoto, Y., Nakada, C., Noguchi, T., Tanigawa, M., Lam Tung, N., Uchida, T., et al., 2010.
MicroRNA-375 is down regulated in gastric carcinomas and regulates cell survival by
targeting PDK1 and 14-3-3 zeta. Cancer Res. 70, 2339-2349.
Tsuruo, T., Naito, M., Tomida, A., Fujita, N., Mashima, T., Sakamoto, H., et al., 2003.
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
Cancer Sci. 94, 15-21.
Tsuruta, F., Sunyama, J., Mori, Y., Hattori, S., Shimizu, S., Tsujimoto, Y., et al., 2004. JNK
promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins.
EMBO J. 23, 1889-1899.
Tsuruta, T., Kozaki, K.I., Uesugi, A., Furuta, M., Hirasawa, A., Imoto, I., et al., 2011. miR-
152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endo-
metrial cancer. Cancer Res. 71, 6450-6462.
Tsutsui, S., Matsuyama, A., Yamamoto, M., Takeuchi, H., Oshiro, Y., Ishida, T., et al., 2010.
The Akt expression correlates with VEGF-A and -C expression as well as microvessel
and lymphatic vessel density in breast cancer. Oncol. Rep. 23, 621-630.
Turley, R.S., Finger, E.C., Hempel, N., How, T., Fields, T.A., Blobe, G.C., 2007. The type III
transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate
cancer. Cancer Res. 67, 1090-1098.
Turner, N.C., Reis-Filho, J.S., Russell, A.M., Springall, R.J., Ryder, K., Steele, D., et al. 2007.
BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 26, 2126-2132.
Udd, L., Makela, T.P., 2011. LKB1 signaling in advancing cell differentiation. Familial Cancer
10 (special issue), 425-435.
Uesugi, A., Kozaki, K.I., Tsuruta, T., Furuta, M., Morita, K.I., Imoto, I., et al., 2011. The
tumor suppressive microRNA miR-218 targets the mTOR component rictor and inhibits
AKT phosphorylation in oral cancer. Cancer Res. 71, 5765-5778.
Uhm, K.O., Lee, E.S., Lee, Y.M., Park, J.S., Kim, S.J., Kim, B.S., et al. 2009. Differential
methylation pattern of ID4, SFRP1, and SHP1 between acute myeloid leukemia and
chronic myeloid leukemia. J. Korean Med. Sci. 24, 493-497 [seen Abstract form only].
Ullmannova, V., Popescu, N.C., 2006. Expression profile of the tumor suppressor genes
DLC-1 and DLC-2 in solid tumors. Int. J. Oncol. 29, 1127-1132.
Ullmannova, V., Popescu, N.C., 2007. Inhibition of cell proliferation, induction of apoptosis,
reactivation of DLC1, and modulation of other gene expression by dietary flavone in
breast cancer cell lines. Cancer Detect. Prevent. 31, 110-118.
Umekita, Y., Ohi, Y., Souda, M., Rai, Y., Sagara, Y., Sagara, Y., et al., 2011. Maspin expres-
sion is frequent and correlates with basal markers in triple-negative breast cancer. Diagn.
Pathol. 6, 36.
Umetani, N., Takeuchi, H., Fujimoto, A., Shinozaki, M., Bilchik, A.J., Hoon, D.S.B., 2004.
Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentia-
tion and unfavorable prognosis. Clin. Cancer Res. 10, 7475-7483.